NCT04109001 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Christensen S, Johansen MB, Christiansen CF, Jensen R, Lemeshow S
Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care. Clin Epidemiol. 2011;3:203-11. doi: 10.2147/CLEP.S20247. Epub 2011 Jun 17.
Cook RJ, Lawless JF
Analysis of repeated events. Stat Methods Med Res. 2002 Apr;11(2):141-66. Review.
Elixhauser A, Steiner C, Harris DR, Coffey RM
Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8-27.

Method of Measuring Comorbidity and Time-point to Predict Readmission and Mortality of Intensive Care Patients: an Observational Study Using Linked Data From National Registers of Hospital Care and Cause of Death

Details for clinical trial NCT04109001

Clinical trial NCT04109001 - References